Calabrese, A.M.; Calsolaro, V.; Rogani, S.; Okoye, C.; Caraccio, N.; Monzani, F. Optimal Type 2 Diabetes Mellitus Management and Active Ageing. Endocrines2021, 2, 523-539.
Calabrese, A.M.; Calsolaro, V.; Rogani, S.; Okoye, C.; Caraccio, N.; Monzani, F. Optimal Type 2 Diabetes Mellitus Management and Active Ageing. Endocrines 2021, 2, 523-539.
Calabrese, A.M.; Calsolaro, V.; Rogani, S.; Okoye, C.; Caraccio, N.; Monzani, F. Optimal Type 2 Diabetes Mellitus Management and Active Ageing. Endocrines2021, 2, 523-539.
Calabrese, A.M.; Calsolaro, V.; Rogani, S.; Okoye, C.; Caraccio, N.; Monzani, F. Optimal Type 2 Diabetes Mellitus Management and Active Ageing. Endocrines 2021, 2, 523-539.
Abstract
Type two diabetes mellitus (T2DM) represents a chronic condition with increasing prevalence worldwide among the older population. T2DM condition increases the risk of micro and macro-vascular complications as well as the risk of geriatric syndromes as falls, fractures and cognitive impairment. The management of T2DM in the older population represents a challenge for the cli-nician, and a Comprehensive Geriatric Assessment should always be prioritized, in order to tailor the glycate haemoglobin target according to functional and cognitive status comorbidities, life ex-pectancy and type of therapy. According to the most recent guidelines, older adults with T2DM should be cathegorized in three groups: healthy patients with good functional status, patients with complications and reduced functionality and patients at the end of life; for each group the target for the glycemic control is different, also according to the type of treatment drug. The therapeutic ap-proach should always begin with lifestyle changes; after that, several lines of therapies are available, with different mechanism of action and potential effect other than glucose level reduction. Partic-ular interest is growing around sodium-glucose cotransporter-2 inhibitors, due to their effect on the cardiovascular system. In this review we evaluate the therapeutic options available for the treat-ment of older diabetic patients, to ensure a correct treatment approach
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
